Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-01T17:03:47.125Z Has data issue: false hasContentIssue false
  • English
  • Français

Gamma-Aminobutyric Acid (GABA) and Sepsis-Related Encephalopathy

Published online by Cambridge University Press:  18 September 2015

T.R. Winder ,
G.Y. Minuk ,
E.J. Sargeant  and
T.P. Seland
T.R. Winder*
Affiliation:
Departments of Clinical Neurosciences and Medicine, University of Calgary
G.Y. Minuk
Affiliation:
Departments of Clinical Neurosciences and Medicine, University of Calgary
E.J. Sargeant
Affiliation:
Departments of Clinical Neurosciences and Medicine, University of Calgary
T.P. Seland
Affiliation:
Departments of Clinical Neurosciences and Medicine, University of Calgary
*
Reed Neurologic Institute, UCLA School of Medicine, Los Angeles, California, U.S.A. 90024
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In order to determine whether disturbances in GABA homeostasis might play a role in the pathogenesis of sepsis-related encephalopathy, serum and brain tissue GABA concentrations from six areas of the brain (cortex, diencephalon, striatum, hippocampus, midbrain, and pons-medulla) were determined in a rat model of bacterial sepsis (cecal ligation and perforation). The results were compared to those obtained from sham operated control animals. All septic animals demonstrated clinical signs of encephalopathy and had elevated serum GABA levels (0.92 ± 0.3 uM versus 0.48 ± 0.15 in controls, p < 0.01). GABA content in the specific subcompartments of the brain, however, were similar in the two groups. These results indicate that although serum GABA levels are elevated during sepsis, GABA is unlikely to play an important role in the pathogenesis of sepsis-related encephalopathy.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 15 , Issue 1 , February 1988 , pp. 23 - 25
Copyright
Copyright © Canadian Neurological Sciences Federation 1988

References

REFERENCES

1.Guidotti, A, Corda, MG, Wise, BC, et al. GABAergic synapses. Supramolecular organization and biochemical regulation. Neuropharmacology 1983; 22: 1471–1479.CrossRefGoogle ScholarPubMed
2.Schafer, DF, Jones, EA. Hepatic encephalopathy and the γ-aminobutyric acid neurotransmitter system. Lancet 1982; 1: 18–20.CrossRefGoogle ScholarPubMed
3.Ferenci, P, Schafer, DF, Kleinberger, G, et al. Serum levels of gamma-aminobutyric acid-like activity in acute and chronic hepatocellular disease. Lancet 1983; 2: 811–814.CrossRefGoogle ScholarPubMed
4.Minuk, GY, Winder, A, Burges, D, Sarjeant, EJ. Serum gammaaminobutyric acid (GABA) levels in patients with hepatic encephalopathy. Hepatogastroenterology 1985; 37: 171–174.Google Scholar
5.Bassett, ML, Mullen, KD, Scholz, B, et al. Increased brain GABA uptake in pre-coma encephalopathy in a rabbit model of fulminant hepatic failure. Hepatology 1985; 5: 1032.Google Scholar
6.Jones, EA, Schafer, DF, Ferenci et al. The neurobiology of hepatic encephalopathy. Hepatology 1984; 4: 1235–1242.CrossRefGoogle Scholar
7.Minuk, GY, Sarjeant, E, Buchan, K. Elevated serum gammaaminobutyric acid (GABA) levels in children with Reye’s syndrome. J Pediatr Gastroenterol Nutr 1985; 4: 528–531.Google ScholarPubMed
8.Minuk, G, Sarjeant, EJ. The effect of A) neomycin and lactulose treatment on portal and systemic plasma GABA levels in rats and B) diazepam, phenobarbital and pH changes on [3H]-GABA binding to isolated rat hepatocytes. Hepatology 1985; 5: 948 (abstr.).Google Scholar
9.Bassett, ML, Mullen, KD, Skolnick, P, et al. GABA and benzodiazepine receptor antagonists ameliorate hepatic encephalopathy in a rabbit model of fulminant hepatic failure. Hepatology 1985; 5: 1032.Google Scholar
10.Sweeney, VP, Perry, TL, Price, JDE, et al. Brain γ-aminobutyric acid deficiency in dialysis encephalopathy. Neurology 1985; 35: 180–184.CrossRefGoogle ScholarPubMed
11.Bansky, G, Meier, PJ, Ziegler, WH, et al. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1985; 1: 1324–1325.Google Scholar
12.Finley, RJ. The metabolic basis of severe sepsis in man. Ann R Coll Phys Surg Can 1976; 9: 133–146.Google Scholar
13.Jeppsson, B, Freund, HR, Simmon, Z, et al. Blood-brain barrier derangement in sepsis: Cause of septic encephalopathy? Am J Sur l981; 141: 1326–142.CrossRefGoogle Scholar
14.Pine, RW, Wertz, MJ, Lennard, ES, et al. Determinant of organ malfunctions or death in patients with intra-abdominal sepsis: A discriminant analysis. Arch Surg 1983; 118: 242–249.CrossRefGoogle ScholarPubMed
15.Schafer, DF, Fowler, JM, Jones, EA. Colonic bacteria: a source of γ-aminobutyric acid in blood. Proc Soc Exp Biol Med 1981; 167: 301–303.CrossRefGoogle ScholarPubMed
16.Minuk, GY. Gamma-aminobutyric acid (GABA) production by eight common bacterial pathogens. Scand J Infect Dis 1986; 18: 465–467.CrossRefGoogle ScholarPubMed
17.Wichterman, KA, Baue, AE, Chaudry, IH. Sepsis and septic shock — a review of laboratory models and a proposal. J Surg Res 1980; 29: 189–201.CrossRefGoogle ScholarPubMed
18.Hare, TA, Manyam, NVB. Rapid and sensitive ion-exchange fluorometric measurement of γ-aminobutyric acid in physiological fluids. Ann Biochem 1980; 101: 349–355.CrossRefGoogle ScholarPubMed
19.Freund, HR, Muggia-Sullam, M, LaFrance, R, et al. Regional brain amino acid and neurotransmitter derangements during abdominal sepsis and septic encephalopathy in the rat. Arch Surg 1986; 121:209–216.CrossRefGoogle ScholarPubMed
20.Plum, F, Posner, JB. The Diagnosis of Stupor and Coma. 3rd Edition. Philadelphia: F.A. Davis Co., 1980.Google Scholar
21.Fischer, JE, et al. Regional brain amino acid and neurotransmitter derangements during abdominal sepsis encephalopathy in the rat. Arch Surg 1987; 121: 209–216.Google Scholar
22.Jackson, AC, etal. The encephalopathy of sepsis. Can J Neurol Sci 1985; 12: 303–307.CrossRefGoogle ScholarPubMed
23.Baraldi, M, Zeneroli, ML. Experimental hepatic encephalopathy: Changes in the binding of γ-aminobutyric acid. Science 1982; 216: 427–428.CrossRefGoogle ScholarPubMed
24.Zeneroli, ML, Baraldi, M, Pinelli, G, et al. Brain receptor changes in portal-systemic encephalopathy in dogs. Hepatology 1985; 5: 953.Google Scholar
25.Baraldi, M, Zeneroli, ML, Ventura, E, et al. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci 1987; 67: 167–175.26.CrossRefGoogle Scholar
26.Minuk, GY. GABAergic mechanisms and their functional importance in the liver. In: Erdo, SL, Bowery, NG, eds. GABAergic Mechanisms in the Mammalian Periphery. New York: Raven Press, 1986; 325–336.Google Scholar
27.Erdo, SL. Peripheral GABAergic mechanisms. Trends in Pharmacological Sciences 1985; 6: 205–208.CrossRefGoogle Scholar
28.Aldegunde, M, Miguez, MI, Fernandez, MP. GABA administered intraperitoneally alters the release of corticosterone in male rats. IRCS Med Sci 1984; 12: 523–524.Google Scholar